title: The use of vesical irrigation system dual pump Endo FMS urology in the endoscopic therapy of the vesical neoplasms.
abstract: OBJECTIVE
  The objective of this study was to determine whether vesical irrigation during transurethral resection of bladder tumours (TURBT) with the dual pump system for the intracavitary irrigation Endo FMS Urology is more efficient than the standard gravity technique.
  
  
  METHODS
  One hundred patients suffering from vesical neoplasms underwent TURBT using the Endo FMS Urology (group A). They were compared to 100 patients previously (2002-2003) treated endoscopically for vesical tumours with the standard endovesical irrigation method (group B).
  
  
  RESULTS
  We demonstrated a reduction of the average time of resection of 10% in favour of patients of group A, a reduction of 39% of the amount of fluid of vesical irrigated in favour of patients of group A. No differences were observed in the recurrence rate of tumours at 3 months and in need of endoscopic revision in the 48 hours following TURBT. Two patients required blood transfusion after TURBT in group B, none in group A. The average time of hospitalisation in group A was less than one day.
  
  
  CONCLUSIONS
  On the basis of this experience the use of Endo FMS Urology Irrigation System in TURBT is strongly recommended.
authors.affiliation: Urology Unit, Casa di Cura Igea, Milano, Italy.
authors.forename: Piero
authors.initials: P
authors.lastname: Larcher
authors.forename: Giorgio
authors.initials: G
authors.lastname: Borroni
authors.forename: Andrea
authors.initials: A
authors.lastname: Begani
authors.forename: Paola
authors.initials: P
authors.lastname: Franch
authors.forename: Luca
authors.initials: L
authors.lastname: Carmignani
mesh_terms: D000328:Adult; D000368:Aged; D003558:Cystoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D007507:Therapeutic Irrigation / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*